Recent research has unveiled ten previously unrecognized symptoms that could indicate an increased risk of severe seizures in pregnant women suffering from preeclampsia, potentially allowing for timely preventive treatments. This groundbreaking finding comes from an international research collaboration.
Preeclampsia, a serious condition during pregnancy, can lead to eclampsia— characterized by the onset of seizures—which poses significant health risks. It remains a leading cause of severe complications and fatalities among pregnant women worldwide. One of the major challenges in managing this condition is the difficulty in predicting which patients are most at risk, as seizures can sometimes occur suddenly without any warning signs.
Identifying Key Symptoms
The research team identified ten symptoms strongly associated with eclampsia, including muscle spasms in the arms or legs, speech difficulties, confusion, hearing impairments, intense dizziness, and concentration problems. These symptoms were rarely reported by women without seizures but frequently presented prior to the onset of an eclamptic seizure. Almost all women affected by eclampsia had experienced at least one of these symptoms, with the likelihood of seizure increases significantly as the number of symptoms rises.
Lina Bergman, a researcher at the University of Gothenburg in Sweden, noted, “Currently, it is difficult to determine who should receive preventive treatment with magnesium sulfate. With the clinical indicators available today, many women who later develop eclampsia are overlooked. The symptoms we’ve identified could enhance timely detection of more cases.”
Magnesium sulfate is utilized to decrease the risk of seizures; however, it requires monitoring and is not administered to all patients. The newly identified symptoms may support more accurate clinical decision-making regarding which individuals should receive treatment.
Study Insights
The study involved 2,142 women in Pakistan and South Africa, with 341 diagnosed with eclampsia, 1,355 experiencing preeclampsia without seizures, and 389 having normotensive pregnancies. The researchers assessed symptoms experienced in the days leading up to a seizure and compared responses among the different groups. The findings were published in the journal PLOS Medicine.
Although the results established a clear link between the symptoms and eclampsia, they do not confirm a causal relationship, as retrospective assessments may introduce some degree of uncertainty.
Stephen Tong, a professor at the University of Melbourne in Australia, commented, “Symptoms currently used, such as headaches and vision changes, show relatively weak associations with eclampsia. Here we see symptoms with much stronger correlations that could better inform clinical decision-making.”
Catherine Cluver, a professor at Stellenbosch University in South Africa, added, “While eclampsia is rare in some regions, it remains a major global health concern. The ability to identify at-risk women earlier could have significant implications, particularly in settings with limited access to advanced care.”
Cited researchers Lina Bergman, Stephen Tong, and Catherine Cluver all contributed equally to the foundational work of this study.
